학술논문
Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C
Document Type
article
Author
Juanjie Tang; Tanya Novak; Julian Hecker; Gabrielle Grubbs; Fatema Tuz Zahra; Lorenza Bellusci; Sara Pourhashemi; Janet Chou; Kristin Moffitt; Natasha B. Halasa; Stephanie P. Schwartz; Tracie C. Walker; Keiko M. Tarquinio; Matt S. Zinter; Mary A. Staat; Shira J. Gertz; Natalie Z. Cvijanovich; Jennifer E. Schuster; Laura L. Loftis; Bria M. Coates; Elizabeth H. Mack; Katherine Irby; Julie C. Fitzgerald; Courtney M. Rowan; Michele Kong; Heidi R. Flori; Aline B. Maddux; Steven L. Shein; Hillary Crandall; Janet R. Hume; Charlotte V. Hobbs; Adriana H. Tremoulet; Chisato Shimizu; Jane C. Burns; Sabrina R. Chen; Hye Kyung Moon; Christoph Lange; Adrienne G. Randolph; Surender Khurana
Source
Nature Communications, Vol 13, Iss 1, Pp 1-10 (2022)
Subject
Language
English
ISSN
2041-1723
Abstract
The antibody response to the SARS-CoV-2 Omicron variant is not well studied in children. Here, the authors provide an age-stratified analysis of SARS-CoV-2 neutralizing capacity of sera from children with acute or convalescent COVID-19 as well as children with multisystem inflammatory syndrome.